Poster Session 2
 
Cancer
C-1 Brodie, Steven G (NIDDK) S. Brodie, X. Xu, W. Qiao, W. Li, L. Cao and C. Deng
  Multiple genetic changes are associated with mammary tumorigenesis in Brca1 conditional knockout mice
 
C-2 Burke, Terrence R. (NCI) T. R. Burke, C.-Q. Wei, Y. Gao, Z.-J. Yao, J. Voigt, J. Wu, D. Yang, N. Atabey, D. Breckenridge, L. Soon, D. P. Bottaro
  Potent Inhibitors of Grb2 SH2 Domain Signalling as Potential New Anticancer Therapeutics
 
C-3 Cao, Liu (NIDDK) Liu Cao, Xiaoling Xu, Steven G Brodie, Wen-Mei Li, Kim, Yansoo and Chu-Xia Deng*; Genetics of Development and Diseases Branch
  Premature cell senescence induced by loss of Brca1 can be overcome by the inactivation of p53 at increased risk of malignant transformation
 
C-4 Dancheck, Barbara Lynn (NCI) B.L. Dancheck, L. Trifiletti, T. Tanaka, L.M. De Luca
  Altered localization of RXRalpha, but not RARalpha, in highly malignant MDA-MB-231 human breast adenocarcinoma cells.
 
C-5 Dracheva, Tatiana V. (NCI) T. Dracheva, T. Nostrand, J. Jen
  Molecular Signatures of Non-Small Cell Lung Cancer
 
C-6 Fujii, Takeshi (NCI) T. Fujii, A. Player, J. Jen
  A Transcriptome Map of Human Non-Small Cell Lung Cancer
 
C-7 Gourgiotis, Loukas (NIDDK) L. Gourgiotis, N. McGriff, G. Csako, L.C. Guthrie, F. Pucino, N.J. Sarlis
  Beneficial Effect of Thyroid Hormone Suppression Therapy (THST) on Adverse Clinical Outcomes in Thyroid Cancer (THYRCA): A Quantitative Research Synthesis
 
C-8 Hong, Jiang (NIDDK) J. Hong, G. Zhang, M.M. Rechler
  Insulin-like growth factor binding protein-3 (IGFBP-3) mutants that do not bind IGF-I or IGF-II stimulate apoptosis in human prostate cancer cells
 
C-9 Kang, Yang (NCI) Y. Kang, S.B. Jakowlew
  Deregulation of G1/S Genes in Lung Tumors of Transforming Growth Factor-beta1 Heterozygous Mice
 
C-10 Lee, Ju-Seog (NCI) Ju-Seog Lee and Snorri S. Thorgeirsson
  Molecular portraits of metastasis: metastasis-associated differences of gene expression in transformed rat liver epithelial cells
 
C-11 Lee, Yun-Sik (NIAAA) Y.S. Lee, J. Won, B.A. Bae, and B. J. Song; Lab. Memb. Biochem. Biophys.
  Elevation of nuclear 8-oxo-deoxyguanosine levels and rapid degradation of p53 tumor suppressor protein by acetaminophen in C6 glioma cells
 
C-12 Li, Hongzhen (NCI) H. Li (1), S. Velasco-Miguel (2), W.C. Vass (1), L.F. Parada(2) and J. E. DeClue(1) 1Laboratory of Cellular Oncology, NCI, 2Center for Developmental Biology, University of Texas Southwestern Medical Center
  EGFR Signaling Pathways Are Associated with Tumorigenesis in NF1/p53 Mouse Tumor Cell Lines
 
C-13 Matyakhina, Ludmila D (NICHD) L. D. Matyakhina, S.D. Pack, E. Pak, J. Jaikumar, P. Mannan, L. S. Kirschner, C. A. Stratakis
  Carney Complex : Cytogenetic Analysis of Tumors
 
C-14 Mock, Beverly A (NCI) Zhang, Shuling-L(1)., Wendy DuBois(1), Edward S. Ramsay(1), Valeri Bliskovski(1), Herbert C. Morse, III(2), Leki Taddesse-Heath(2), Xiaolan Qian(3), William C. Vass(3), Ronald A. DePinho(4) and Beverly A. Mock(1).
  Efficiency alleles of Pctr1 and Pctr2 as Modifiers of Plasmacytoma Susceptibility
 
C-15 Muniz-Medina, Vanessa (NCI) V. Muniz-Medina, C. Van Waes, Z. Chen, J. Schlom, J. Greiner, B. Clark, B. Kachar and E. Kass
  Establishment of a continuous line of poorly differentiated carcinoma cells from BALB/c mice
 
C-16 Mysliwiec, Pauline Ann (NCI) P. A. Mysliwiec, MD, A. Alberg, PhD, K. Helzhouser, MD
  Colorectal Cancer Testing: Behaviors & Determinants in a Cohort
 
C-17 Peters, Ulrike (NCI) U. Peters, R. Sinha, N. Chatterjee, A. Subar, R. Ziegler, R. Bresalier, J.L. Weissfeld, A. Flood, R.N. Hoover, A. Schatzkin, R.B. Hayes and the PLCO Project Team
  Dietary Fiber and Colorectal Adenoma
 
C-18 Pickworth, Wallace (NIDA) W. Pickworth, S. Steckley, G. Soon, H. Haverkos
  Cigarette smoking and Cervical cancer: A meta-analysis
 
C-19 Reppert, Tricia Elizabeth (NCI) T. Reppert, R. Yonescu, T. Brown, T. Knutsen, T. Ried, and I. Kirsch
  The Cancer Chromosome Aberration Project, CCAP: Managing Genetic Information via Cytogenetics
 
C-20 Rockwood, Lynne D. (NCI) L.D.Rockwood, S.Janz
  Genomic Instability in Mouse Burkitt's Lymphoma is Predominated by Recombinations and Deletions, Not Point Mutations